Life Science Council
Springboard’s Life Science Council is a well connected, highly respected group of experts across the world of biotech, pharma, medical devices and health IT who invest their “human capital” in Springboard and our pipeline of high-growth, women-led companies.
Members advise and support our annual life science industry initiatives by actively advocating on behalf of Springboard among peers and within the business community and by leveraging their expertise and network to provide connections, perspective, prestige and strategic input.
Susan Acker-Walsh | Managing Partner, CREO, Inc.
Jahanara Ali | Founder & CEO, Octane LLC
Letizia Amadini-Lane | VP of Strategic Alliances for the Office of the CEO, Sanford Burnham Prebys Medical Discovery Institute
Debra Apruzzese | President, Axia11G Consulting Group, LLC
Carol Ashe | Chief Business Officer, New York Genome Center
Sheila Babnis | Health IT Lab Fellow, Columbia University
Faz Bashi | Chair of Digital Health and Sciences Screening Committee, Life Science Angels
Kian Beyzavi | President, Kbeyzavi & Associates
Angèle Maki | Executive Director, Business Development & Licensing, Merck & Co.
Janice Bourque | Managing Director, Life Sciences at Hercules Technology Growth Capital
Rachel Braun Scherl | Co-Founder & Principal, SPARK Solutions for Growth
Laura Brege | Managing Director, Cervantes Life Science Partners
Corinne Bright | Founder & CEO, Reflex Medical, Tulavi Therapeutics
Andrea Bruell | Former VP of New Product Commercialization and Specialty Products, Biogen Idec
Jill Carroll | Principal, SR One
Vita Cassese | CEO, Mardon Management Advisors
Faith Charles | Partner & Chair of Life Sciences, Thompson Hine LLP
Terry Chase | Sponsored Research Director, Celltex Therapeutics Corporation
Pravin Chaturvedi | Co-founder & CEO, Oceanyx Pharmaceuticals
Martha Connolly | Former Director of MTech Baltimore, University of Maryland
Pamela Contag, PhD | CEO, BioEclipse Therapeutics
Ellen Corenswet | Corporate Partner, Covington & Burling LLP
Molly Coye | Executive in Residence, AVIA
Suzanne Cross | Former Global Head of Consumer Business Development Operation and Alliance Management, Johnson & Johnson
Leena Das-Young | VP, Head of Late Phase Stage Strategy and Development Group, Oncology Global Product Development, Pfizer
Amy Davis | Senior Director Clinical Information and Process Automation, Eli Lilly & Company
Teresa DeLuca | Managing Director, NY Life Science Venture Fund
Rachel DeScenza | Vice President of Medicare Integration, AETNA
Ann DeWitt | Senior Director & COO, the Engine
Karen Drexler | CEO, Sandstone Diagnostics, Inc.
Suzette Dutch | Owner, Triathlon Medical Ventures
Joan Fallon | Founder & CEO, Curemark
Stacy Feld | Vice President of Consumer Venture Investments & External Innovation, Johnson and Johnson
Kathe P. Fox, Ph.D. | Head of Informatics, Aetna
Pamela Goldberg | President & CEO, Medical Device Innovation Consortium
Jennifer Friel Goldstein | Market Manager, Silicon Valley Bank
Megan Gates | Partner, Mintz Levin
Cyndi Green | Senior Director of Worldwide Business Development, Pfizer
Jill Griffiths | President, Griffiths Communications
Adele Gulfo | Chief of Commercial Development, Roivant Sciences
Joseph Gulfo | Executive Director & Professor of Health Sciences, Lewis Center for Healthcare Innovation and Technology
Laurie Halloran | President & CEO, Halloran Consulting Group
Elma Hawkins | Former President & CEO, Lion Biotechnologies, Cerulean BioVentures, Viridian Pharmaceuticals
Jane Pritchett Henderson | CFO & SVP of Corporate Development, Voyager Therapeutics, Inc.
Linda Hogan | President & Founder, LLH Associates
Mary Holland | Former Global Business Development Strategist for the Molecular Diagnostics Division, MRI Global
Claire Houston | VP of Clinical Development, Pulsar Vascular; Principal, CSH Consulting Services
Irene Hrusovsky | Managing Director, BELLE Capital USA
Nan Hutchinson | Former Board Member, Cynapsus Therapeutics
Eva Jack | Chief Business Officer, Mersana Therapeutics
Elizabeth Jeffords | Former VP Ophthalmology, Genentech
Annalisa Jenkins | CEO, PlaqueTech
Chris Jones | Chief Ventures Investment Officer, University of Vermont Health Network
Kristi Jones | Former VP, Head of Portfolio Strategy and Management, AstraZeneca/MedImmune
Veronica Jordan | Managing Director, Golden Seeds
Sofija Jovic | CEO, ProPhase
Anjali Kataria | CEO, Mytonomy, Inc.
Nina Kjellson | General Partner, Canaan Partners
Thomas Kluz | Senior Venture Capital Associate, Providence Ventures
Summer Knight | CEO, Firecracker Health
Jac Leonardi | Chairman & CEO, ActivCore
Kate Liebelt | Chief of Staff, Deloitte
Lucy Lu | Board Member, Life Science Angels
Ellen Lubman | Founder, Bella Biotech Advisory
Rebecca MacKinnon | Partner, 5th Dimension Strategies LLC
Stacie Mallen | Former VP of Human Resources, Ulthera
Anna Maroney | VP of Alliance Management, AbbVie
Sharon Mates | Chairman & CEO, Intra-Cellular Therapies Inc.
Sylvia McBrinn | CEO & Founder, McBrinn Management Consulting
Irena Melnikova | Investment Banking, Leerink Partners LLC
David S. Memel | Managing Director, Klaipeda Health
Nancy Miller-Rich | Former SVP, Merck Global Human Health
Leslie Molony | Executive Director of Business Development, Ology Bioservices, Inc., and Nanotherapeutics, Inc.
Julie Murchinson | CEO, Health Evolution
Anahita Nakhjiri | Senior Associate, McKesson Ventures
Nina Nashif | Founder & Former CEO, Healthbox
Azin Nezami | Director of Innovation and External Research, Vertex Pharmaceuticals
Sara Núñez-García | Senior Director, Roivant Sciences
Catherine Oyler | Global Head of Strategy and Operations, Johnson & Johnson Global External Innovation
Valerie Palmieri | CEO, Vermillion
Heather Preston | Partner & Managing Director, TPG Biotech
Helen Quick | Managing Director, Locust Point Capital
Lee Rauch | Executive in Residence, Columbia Technology Ventures
Eiry Roberts | Chief Medical Officer, Neurocrine Biosciences
Susan Rohrer | Former Merck & Co., Inc.
Mary Rozenman, PhD | SVP of Corporate Development and Strategy, Aimmune Therapeutics
Barbara Ryan | Founder, Barbara Ryan Advisors
Corsee Sanders, PhD | Executive Vice President, Development Operations, Juno Therapeutics, Inc.
Adriann Sax | Entrepreneur in Residence, Fortress Biotech
Catherine Sazdanoff | Chief Business Officer, Strata Oncology
Rachel Sha | Vice President of Digital Business Development & Licensing, Sanofi
Nick Shah, PhD | Head of Assay Science, DiCE Molecules
Anya Schiess | Co-Founder & General Partner, Healthy Ventures
Kay Schwichtenberg | President & CEO, Central Life Sciences
Stacey Seltzer | Partner, Aisling Capital
Amita Shukla | Founder & CEO, Vitamita
Shweta Singh | Principal, Marketing, Cross BioOncology Account Management, and Biomarker Testing, Genentech
Catherine Sohn | President, Sohn Health Strategies, LLC
Karen Spilizewski | Vice President, RiverVest Venture Partners
Lilian Stern | Principal, Stern Investor Relations
Diane Sullivan | Former VP of Market Research and Patient Strategies, AstraZeneca
Alison Taunton-Rigby | Director & Trustee, Healthcare, Life Sciences and Financial Services
Dr. Nick van Terheyden | Chief Medical Officer, BaseHealth, Inc.
Murielle Thinard-McLane | COO, Genome Medical, Inc.
Julia Varshavsky | Director of Biometrics, Corcept Therapeutics
Alan Walker | VP of Marketing & Development, Kaneka Americas Inc.
Nicole Walker | Healthcare Principal, Baird Capital